| Bioactivity | DBM-C5-VC-PAB-MMAE (Compound 3a) is a Drug-Linker conjugate for ADC. DBM-C5-VC-PAB-MMAE is composed of a linker C5-VC-PAB with a maleimide group DBM and an ADC toxin MMAE (HY-15162)[1]. |
| CAS | 1644228-55-6 |
| Formula | C68H103Br2N11O15 |
| Molar Mass | 1474.42 |
| Appearance | 固体 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
| Reference | [1]. Feuillâtre O, et al., Impact of Maleimide Disubstitution on Chemical and Biological Characteristics of HER2 Antibody-Drug Conjugates. ACS Omega. 2020 Jan 17;5(3):1557-1565. |
DBM-C5-VC-PAB-MMAE
CAS: 1644228-55-6 F: C68H103Br2N11O15 W: 1474.42
DBM-C5-VC-PAB-MMAE (Compound 3a) is a Drug-Linker conjugate for ADC. DBM-C5-VC-PAB-MMAE is composed of a linker C5-VC-PA
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.